Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.

Author: MahmoudR, MathiasS D, PastaD J, PayneR, WankeL A, WilliamsR

Paper Details 
Original Abstract of the Article :
To compare pain-related treatment satisfaction, patient-perceived side effects, functioning, and well-being in patients with advanced cancer who were receiving either transdermal fentanyl (Duragesic, Janssen Pharmaceuticals, Titusville, NJ) or sustained-release oral forms of morphine (MS Contin, Per...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1200/JCO.1998.16.4.1588

データ提供:米国国立医学図書館(NLM)

Managing Cancer Pain: A Comparison of Transdermal Fentanyl and Oral Morphine

Cancer pain is a significant challenge for patients undergoing treatment. This study, published in the journal [Journal Name], compares the effectiveness of transdermal fentanyl to oral morphine in managing cancer pain.

The study examines the pain-related treatment satisfaction, patient-perceived side effects, functioning, and well-being of patients with advanced cancer receiving either transdermal fentanyl or sustained-release oral morphine. The study found that patients receiving transdermal fentanyl reported higher pain-related treatment satisfaction and fewer side effects compared to those receiving oral morphine. They also experienced improved functioning and well-being.

Finding Relief from Cancer Pain

This study suggests that transdermal fentanyl may be a more effective and well-tolerated option for managing cancer pain compared to oral morphine. Its ability to provide sustained pain relief with fewer side effects could significantly improve the quality of life for patients with cancer pain.

A Journey Towards Better Pain Management

This study highlights the importance of individualized pain management approaches, taking into account the unique needs and preferences of each patient. It emphasizes the importance of ongoing communication between patients and healthcare providers to ensure that pain relief strategies are effective and well-tolerated. It’s a reminder that even in the seemingly endless expanse of medical research, breakthroughs can emerge, bringing hope and healing to those who need it most.

Dr.Camel's Conclusion

Transdermal fentanyl emerges as a potential alternative to oral morphine in managing cancer pain, offering higher patient satisfaction, fewer side effects, and improved functioning and well-being. This study underscores the importance of individualized pain management approaches, tailored to meet the unique needs of each patient. It’s a reminder that even in the seemingly endless expanse of medical research, breakthroughs can emerge, bringing hope and healing to those who need it most.

Date :
  1. Date Completed 1998-05-12
  2. Date Revised 2022-03-17
Further Info :

Pubmed ID

9552070

DOI: Digital Object Identifier

10.1200/JCO.1998.16.4.1588

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.